Myriad Genetics and the American Civil Liberties Union are taking the next step in their court battle over the legitimacy of Myriad's BRCA patents. As our sister publication GenomeWeb Daily News reports, a US Federal Circuit Court of Appeals recently upheld Myriad's right to patent the genes, and then declined to rehear the case. The ACLU is now going to the Supreme Court in its bid to get the patents overturned.